Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06494306

Characterization of Olfactory Perception in Post-Traumatic Stress Disorder

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The core symptoms of post-traumatic stress disorder (PTSD) include flash backs, intrusive pictures and thoughts related to the traumatic event, hyperalertness, avoidance of traumatic relevant environmental triggers and emotional dysregulation. Some studies suggest that PTSD is also associated with impaired olfactory perception, which seems quite intuitive regarding the close anatomical-functional connections between olfactory and emotional circuits. Furthermore, some studies reported that olfactory stimuli can trigger flashbacks in subjects with PTSD. However, up to know available data is scarce and heterogeneous concerning that topic. The goal of the study is to determine the olfactory phenotype of subjects with PTSD. More precisely, this project aims at filling the above mentioned gap by systematically assessing the olfactory perception of subjects with PTSD along five dimensions: olfactory identity, hedonic value, familiarity, desirability and edibility. As a secondary goal, the relative weight of olfaction compared to the other senses in the relived memories of subjects with PTSD will be assessed. The investigators here hypothesize a global impairment in olfactory processing (intensity, hedonicity, familiarity and edibility judgments) in PTSD subjects, compared with healthy subjects.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEuropean Test of Olfactory Capabilities (ETOC)Investigators will collect the ETOC score in patient of both arms
BEHAVIORALStandardized Hedonicity TestTo smell 20 odorant solutions and for each odor and evaluate it along five dimensions: familiarity, hedonicity, edibility, desire to smell again, perceived intensity). Each dimension is assessed with a Likert scale (from 1 (not at all) to 9 (extremely))
BEHAVIORALQuestionnairesPatients with PTSD will have the following questionnaires : PTSD Checklist for Diagnostic and Statistical Manual (DSM)-V (PCL-5), Peri-trauma Dissociation Experience Questionnaire (PDEQ), Patient Health Questionnaire-9 (PHQ9), Snaith-Hamilton Pleasure Scale (SHAPS), Childhood Trauma Questionnaire (CTQ) and Apathy Evaluation Scale (AES)
BEHAVIORALOdor / trauma association questionnairePatients with PTSD will have Odor / trauma association questionnaire

Timeline

Start date
2024-08-26
Primary completion
2026-08-25
Completion
2026-08-25
First posted
2024-07-10
Last updated
2024-07-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06494306. Inclusion in this directory is not an endorsement.